Skip to main content

previous disabled Page of 9
and
  1. Article

    Open Access

    Master corepressor inactivation through multivalent SLiM-induced polymerization mediated by the oncogene suppressor RAI2

    While the elucidation of regulatory mechanisms of folded proteins is facilitated due to their amenability to high-resolution structural characterization, investigation of these mechanisms in disordered protein...

    Nishit Goradia, Stefan Werner, Edukondalu Mullapudi in Nature Communications (2024)

  2. Article

    Open Access

    Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells

    Circulating tumor cells (CTCs) hold immense promise for unraveling tumor heterogeneity and understanding treatment resistance. However, conventional methods, especially in cancers like non-small cell lung canc...

    Lisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, David Agorku in Molecular Cancer (2024)

  3. Article

    Open Access

    HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis

    Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis ...

    Svenja Schneegans, Jana Löptien in Journal of Experimental & Clinical Cancer … (2024)

  4. Article

    Open Access

    Clinical applications of circulating tumor cells in patients with solid tumors

    The concept of liquid biopsy analysis has been established more than a decade ago. Since the establishment of the term, tremendous advances have been achieved and plenty of methods as well as analytes have bee...

    Daniel J. Smit, Svenja Schneegans, Klaus Pantel in Clinical & Experimental Metastasis (2024)

  5. Article

    Open Access

    Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection

    The proliferation marker Ki-67 is a major pathological feature for the description of the state of disease in breast cancer. It helps to define the molecular subtype and to stratify between therapy regimens in...

    Thomas M. Deutsch, Chiara Fischer, Fabian Riedel in Archives of Gynecology and Obstetrics (2024)

  6. Article

    Open Access

    EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) has high recurrence rates exceeding 50% despite curative resection. The serum biomarker alpha-fetoprotein (AFP) is a well-known prognostic marker for HCC. EpCAM-positive circulat...

    Lorenz Kocheise, Martin Schoenlein, Berit Behrends, Vincent Joerg in Scientific Reports (2023)

  7. Article

    Open Access

    RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer

    Triple-negative breast cancer (TNBC) is the most difficult breast cancer subtype to treat due to the lack of targeted therapies. Cancer stem cells (CSCs) are strongly enriched in TNBC lesions and are responsib...

    Evangelos Prokakis, Shaishavi Jansari, Angela Boshnakovska in Cell Death & Disease (2023)

  8. Article

    Circulating tumour cells for early detection of clinically relevant cancer

    Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early detection are paramount to reducing cancer-related deaths and improving patient outcomes. Increasing evidence in...

    Rachel Lawrence, Melissa Watters, Caitlin R. Davies in Nature Reviews Clinical Oncology (2023)

  9. Article

    Open Access

    A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer

    Metastatic castration-resistant prostate cancer (mCRPC) is an immunologically cold disease with dismal outcomes. Cryoablation destroys cancer tissue, releases tumor-associated antigens and creates a pro-inflam...

    Liv Cecilie Vestrheim Thomsen, Alfred Honoré in Cancer Immunology, Immunotherapy (2023)

  10. Article

    Open Access

    Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value

    Circulating tumour cells (CTCs) are mainly enriched based on the epithelial cell adhesion molecule (EpCAM). Although it was shown that an EpCAM low-expressing CTC fraction is not captured by such approaches, k...

    André Franken, Annika Kraemer, Alicia Sicking, Meike Watolla in British Journal of Cancer (2023)

  11. Article

    Open Access

    Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors

    Cancer is one of the three leading causes of death worldwide. Even after successful therapy and achieving remission, the risk of relapse often remains. In this context, dormant residual cancer cells in seconda...

    Isabel Heidrich, Benjamin Deitert, Stefan Werner in Cancer and Metastasis Reviews (2023)

  12. No Access

    Article

    Experimental in vitro, ex vivo and in vivo models in prostate cancer research

    Androgen deprivation therapy has a central role in the treatment of advanced prostate cancer, often causing initial tumour remission before increasing independence from signal transduction mechanisms of the an...

    Verena Sailer, Gunhild von Amsberg, Stefan Duensing, Jutta Kirfel in Nature Reviews Urology (2023)

  13. No Access

    Chapter and Conference Paper

    Label Efficient Classification in Liquid Biopsy Data by Self-supervision

    A cut-off of 5 circulating tumor cells (CTCs) per 7.5 ml of blood in metastatic breast cancer patients is highly predictive of progression-free survival and overall survival. These rare events potentially refl...

    Hümeyra Husseini, Maximilian Nielsen, Klaus Pantel in Bildverarbeitung für die Medizin 2023 (2023)

  14. Article

    Open Access

    Regulation of bone homeostasis by MERTK and TYRO3

    The fine equilibrium of bone homeostasis is maintained by bone-forming osteoblasts and bone-resorbing osteoclasts. Here, we show that TAM receptors MERTK and TYRO3 exert reciprocal effects in osteoblast biolog...

    Janik Engelmann, Jennifer Zarrer, Victoria Gensch in Nature Communications (2022)

  15. Article

    Open Access

    Characterization of immunologically detectable T-cell sensitization, Immunohistochemical detection of pro-inflammatory cytokines, and clinical parameters of patients after allogeneic intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans

    The null hypotheses were tested that intraoral bone augmentation using two different allogeneic materials has no impact on the patient’s blood levels of material-specific lymphocytes and on the immunohistochem...

    Önder Solakoglu, Werner Götz, Volker von Baehr, Guido Heydecke in BMC Oral Health (2022)

  16. Article

    Open Access

    Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions

    Human papilloma virus (HPV) is an infectious carcinogenic agent. Nearly all cervical cancers are positive for one of the high-risk HPV subtypes. Although the introduction of the HPV vaccines in many countries ...

    Johanna Herbst, Klaus Pantel, Katharina Effenberger in British Journal of Cancer (2022)

  17. Article

    Open Access

    Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade

    Metastasis formation is the main cause of cancer-related death in patients with solid tumours. At the beginning of this process, cancer cells escape from the primary tumour to the blood circulation where they ...

    Zahra Eslami-S, Luis Enrique Cortés-Hernández, Frédéric Thomas in British Journal of Cancer (2022)

  18. Article

    Open Access

    Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma

    Advanced cutaneous squamous cell carcinoma (cSCC) encompasses unresectable and metastatic disease. Although immune checkpoint inhibition has been approved for this entity recently, a considerable proportion of...

    Glenn Geidel, Isabel Heidrich, Julian Kött, Stefan W. Schneider in npj Precision Oncology (2022)

  19. Article

    Open Access

    Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses

    Circulating tumor cells (CTCs) are liquid biopsies that represent micrometastatic disease and may offer unique insights into future recurrences in non-small cell lung cancer (NSCLC). Due to CTC rarity and limi...

    Kanve N. Suvilesh, Yulia I. Nussbaum, Vijay Radhakrishnan in Molecular Cancer (2022)

  20. Article

    Open Access

    Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

    Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against androgen synthesis or AR activati...

    Lina Merkens, Verena Sailer, Davor Lessel in Journal of Experimental & Clinical Cancer … (2022)

previous disabled Page of 9